Concepts (295)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 19 | 2019 | 409 | 2.890 |
Why?
|
| Mammography | 12 | 2017 | 47 | 2.180 |
Why?
|
| Kidney Failure, Chronic | 16 | 2021 | 124 | 1.890 |
Why?
|
| Racism | 4 | 2022 | 31 | 1.850 |
Why?
|
| Early Detection of Cancer | 5 | 2018 | 102 | 1.730 |
Why?
|
| Healthcare Disparities | 7 | 2023 | 88 | 1.700 |
Why?
|
| Health Services Accessibility | 13 | 2021 | 112 | 1.590 |
Why?
|
| Health Status Disparities | 5 | 2020 | 75 | 1.530 |
Why?
|
| Renal Replacement Therapy | 9 | 2011 | 17 | 1.450 |
Why?
|
| Registries | 15 | 2010 | 189 | 1.440 |
Why?
|
| Kidney Transplantation | 9 | 2021 | 119 | 1.410 |
Why?
|
| Medically Uninsured | 2 | 2021 | 13 | 1.220 |
Why?
|
| Physicians | 2 | 2022 | 122 | 1.080 |
Why?
|
| Humans | 75 | 2023 | 27072 | 0.970 |
Why?
|
| Primary Health Care | 3 | 2021 | 83 | 0.890 |
Why?
|
| Practice Patterns, Physicians' | 5 | 2018 | 111 | 0.880 |
Why?
|
| Health Facilities | 1 | 2023 | 23 | 0.810 |
Why?
|
| Health Equity | 1 | 2023 | 18 | 0.800 |
Why?
|
| Academic Medical Centers | 2 | 2021 | 132 | 0.790 |
Why?
|
| Middle Aged | 42 | 2021 | 8923 | 0.790 |
Why?
|
| Female | 55 | 2021 | 15212 | 0.780 |
Why?
|
| Chicago | 23 | 2019 | 949 | 0.780 |
Why?
|
| Human Rights | 1 | 2022 | 3 | 0.780 |
Why?
|
| Referral and Consultation | 3 | 2021 | 88 | 0.740 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 144 | 0.740 |
Why?
|
| Ambulatory Care Facilities | 1 | 2021 | 39 | 0.720 |
Why?
|
| Health Personnel | 1 | 2022 | 94 | 0.720 |
Why?
|
| Community Health Services | 1 | 2021 | 34 | 0.720 |
Why?
|
| Dyslipidemias | 2 | 2018 | 16 | 0.710 |
Why?
|
| Renal Dialysis | 10 | 2021 | 84 | 0.700 |
Why?
|
| Adult | 36 | 2021 | 7831 | 0.700 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 55 | 0.680 |
Why?
|
| Cardiovascular Diseases | 4 | 2018 | 321 | 0.670 |
Why?
|
| Emergency Service, Hospital | 4 | 2022 | 255 | 0.660 |
Why?
|
| Hospitalization | 2 | 2022 | 300 | 0.650 |
Why?
|
| Mass Screening | 10 | 2017 | 167 | 0.650 |
Why?
|
| Cancer Care Facilities | 1 | 2019 | 7 | 0.640 |
Why?
|
| Carcinoma, Ductal | 1 | 2019 | 5 | 0.630 |
Why?
|
| Socioeconomic Factors | 11 | 2020 | 302 | 0.630 |
Why?
|
| Cholesterol, LDL | 2 | 2018 | 29 | 0.610 |
Why?
|
| Practice Guidelines as Topic | 7 | 2018 | 261 | 0.600 |
Why?
|
| Social Determinants of Health | 1 | 2018 | 32 | 0.580 |
Why?
|
| Violence | 1 | 2018 | 39 | 0.580 |
Why?
|
| Aged | 31 | 2021 | 8997 | 0.580 |
Why?
|
| Survival Rate | 6 | 2010 | 342 | 0.560 |
Why?
|
| Mortality | 5 | 2018 | 89 | 0.540 |
Why?
|
| Multicenter Studies as Topic | 3 | 2010 | 43 | 0.510 |
Why?
|
| Health Policy | 2 | 2015 | 42 | 0.490 |
Why?
|
| Residence Characteristics | 5 | 2019 | 214 | 0.490 |
Why?
|
| Undocumented Immigrants | 1 | 2015 | 2 | 0.490 |
Why?
|
| Value of Life | 1 | 2015 | 1 | 0.480 |
Why?
|
| Insurance Coverage | 1 | 2015 | 15 | 0.470 |
Why?
|
| United Kingdom | 11 | 2011 | 47 | 0.470 |
Why?
|
| Pregnancy Outcome | 3 | 2014 | 20 | 0.470 |
Why?
|
| Peritoneal Dialysis | 3 | 2011 | 26 | 0.450 |
Why?
|
| Male | 31 | 2021 | 14772 | 0.430 |
Why?
|
| Young Adult | 12 | 2021 | 1994 | 0.420 |
Why?
|
| Hospitals | 4 | 2022 | 167 | 0.420 |
Why?
|
| Waiting Lists | 2 | 2010 | 18 | 0.410 |
Why?
|
| Outpatient Clinics, Hospital | 4 | 2002 | 15 | 0.400 |
Why?
|
| United States | 10 | 2021 | 2035 | 0.400 |
Why?
|
| Community Health Planning | 2 | 2009 | 20 | 0.390 |
Why?
|
| Cause of Death | 3 | 2010 | 60 | 0.390 |
Why?
|
| Tissue Donors | 2 | 2010 | 79 | 0.390 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2019 | 637 | 0.380 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 891 | 0.370 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2019 | 810 | 0.370 |
Why?
|
| Hemoglobins | 4 | 2009 | 33 | 0.370 |
Why?
|
| Retrospective Studies | 11 | 2021 | 3538 | 0.360 |
Why?
|
| Adolescent | 9 | 2021 | 2172 | 0.360 |
Why?
|
| National Health Programs | 2 | 2010 | 3 | 0.350 |
Why?
|
| Cesarean Section | 4 | 2014 | 30 | 0.350 |
Why?
|
| Renal Insufficiency | 1 | 2010 | 12 | 0.340 |
Why?
|
| Risk Assessment | 7 | 2018 | 624 | 0.330 |
Why?
|
| Community Participation | 1 | 2009 | 17 | 0.320 |
Why?
|
| Risk Factors | 10 | 2018 | 2302 | 0.320 |
Why?
|
| ErbB Receptors | 1 | 2009 | 54 | 0.310 |
Why?
|
| Breech Presentation | 1 | 2008 | 3 | 0.310 |
Why?
|
| Version, Fetal | 1 | 2008 | 3 | 0.310 |
Why?
|
| Medical Audit | 1 | 2008 | 5 | 0.310 |
Why?
|
| Aged, 80 and over | 11 | 2018 | 4777 | 0.300 |
Why?
|
| Pregnancy | 8 | 2020 | 336 | 0.300 |
Why?
|
| Incidence | 8 | 2019 | 759 | 0.290 |
Why?
|
| Smoking | 2 | 2005 | 176 | 0.280 |
Why?
|
| Hospitals, Public | 6 | 2002 | 27 | 0.280 |
Why?
|
| Poverty | 6 | 2010 | 96 | 0.270 |
Why?
|
| Diabetes Mellitus | 3 | 2005 | 127 | 0.270 |
Why?
|
| Annual Reports as Topic | 3 | 2010 | 3 | 0.260 |
Why?
|
| Guideline Adherence | 3 | 2018 | 56 | 0.250 |
Why?
|
| Intubation | 1 | 2005 | 6 | 0.250 |
Why?
|
| Heroin Dependence | 1 | 2005 | 9 | 0.250 |
Why?
|
| Cocaine-Related Disorders | 1 | 2005 | 13 | 0.250 |
Why?
|
| Public Health | 2 | 2017 | 69 | 0.250 |
Why?
|
| Extraction, Obstetrical | 2 | 1995 | 2 | 0.250 |
Why?
|
| Tobacco Use Disorder | 1 | 2005 | 18 | 0.240 |
Why?
|
| Smoking Cessation | 1 | 2005 | 47 | 0.230 |
Why?
|
| Geographic Information Systems | 1 | 2004 | 4 | 0.230 |
Why?
|
| Diabetes, Gestational | 2 | 2014 | 9 | 0.230 |
Why?
|
| Time Factors | 6 | 2018 | 1433 | 0.220 |
Why?
|
| Treatment Outcome | 5 | 2018 | 3485 | 0.220 |
Why?
|
| Age Factors | 6 | 2018 | 766 | 0.220 |
Why?
|
| New Zealand | 6 | 2019 | 11 | 0.220 |
Why?
|
| Health Status Indicators | 1 | 2004 | 72 | 0.220 |
Why?
|
| Cities | 3 | 2018 | 15 | 0.210 |
Why?
|
| Asthma | 1 | 2005 | 156 | 0.210 |
Why?
|
| Commerce | 1 | 2023 | 12 | 0.210 |
Why?
|
| Uterine Cervical Neoplasms | 5 | 1994 | 30 | 0.200 |
Why?
|
| Patient Transfer | 2 | 1996 | 21 | 0.200 |
Why?
|
| Uncompensated Care | 1 | 2002 | 2 | 0.200 |
Why?
|
| Databases, Factual | 3 | 2019 | 347 | 0.190 |
Why?
|
| Delivery, Obstetric | 2 | 2019 | 12 | 0.190 |
Why?
|
| Morbidity | 2 | 2001 | 54 | 0.190 |
Why?
|
| Health Priorities | 1 | 2001 | 4 | 0.190 |
Why?
|
| Public Health Administration | 1 | 2001 | 9 | 0.190 |
Why?
|
| Patient Compliance | 3 | 2018 | 150 | 0.190 |
Why?
|
| Social Class | 3 | 2010 | 67 | 0.180 |
Why?
|
| Aftercare | 1 | 2021 | 24 | 0.180 |
Why?
|
| Health Surveys | 3 | 2007 | 86 | 0.170 |
Why?
|
| Research Design | 2 | 2020 | 185 | 0.170 |
Why?
|
| Dystocia | 1 | 2020 | 1 | 0.170 |
Why?
|
| Neoplasms | 2 | 2017 | 237 | 0.160 |
Why?
|
| Income | 2 | 2005 | 80 | 0.160 |
Why?
|
| Cholesterol | 2 | 2018 | 64 | 0.160 |
Why?
|
| Sociology, Medical | 1 | 2019 | 3 | 0.160 |
Why?
|
| Comorbidity | 3 | 2017 | 481 | 0.160 |
Why?
|
| Hospitals, Urban | 2 | 1998 | 34 | 0.150 |
Why?
|
| Quality of Health Care | 4 | 2020 | 102 | 0.150 |
Why?
|
| Survival Analysis | 2 | 2009 | 257 | 0.150 |
Why?
|
| Mortality, Premature | 1 | 2018 | 6 | 0.150 |
Why?
|
| Illinois | 4 | 2015 | 250 | 0.150 |
Why?
|
| Global Health | 1 | 2018 | 36 | 0.150 |
Why?
|
| Infant, Low Birth Weight | 1 | 2018 | 18 | 0.150 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 18 | 0.150 |
Why?
|
| General Practice | 1 | 2018 | 2 | 0.150 |
Why?
|
| Biomarkers | 2 | 2018 | 562 | 0.150 |
Why?
|
| Germany | 1 | 2017 | 5 | 0.150 |
Why?
|
| Infant, Newborn | 5 | 2019 | 642 | 0.140 |
Why?
|
| Women's Health | 2 | 2017 | 174 | 0.140 |
Why?
|
| Wales | 4 | 2010 | 5 | 0.140 |
Why?
|
| Medical Overuse | 1 | 2017 | 7 | 0.140 |
Why?
|
| England | 4 | 2010 | 14 | 0.140 |
Why?
|
| Down-Regulation | 1 | 2017 | 99 | 0.140 |
Why?
|
| Prevalence | 5 | 2014 | 443 | 0.140 |
Why?
|
| False Negative Reactions | 1 | 2016 | 14 | 0.130 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 161 | 0.130 |
Why?
|
| Health Education | 3 | 1994 | 48 | 0.130 |
Why?
|
| Quality Control | 1 | 2016 | 27 | 0.130 |
Why?
|
| Facility Regulation and Control | 1 | 1996 | 1 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 482 | 0.130 |
Why?
|
| Quality Assurance, Health Care | 1 | 2016 | 30 | 0.130 |
Why?
|
| Urban Health | 3 | 2004 | 22 | 0.130 |
Why?
|
| Observer Variation | 1 | 2016 | 96 | 0.130 |
Why?
|
| Epidemiologic Methods | 2 | 2015 | 17 | 0.130 |
Why?
|
| Neoplasm Staging | 3 | 2018 | 363 | 0.130 |
Why?
|
| Emergency Medical Services | 1 | 1996 | 28 | 0.130 |
Why?
|
| Urban Population | 5 | 2005 | 153 | 0.130 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 30 | 0.120 |
Why?
|
| Civil Defense | 1 | 2015 | 4 | 0.120 |
Why?
|
| Patient Safety | 1 | 2016 | 39 | 0.120 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2015 | 7 | 0.120 |
Why?
|
| Financing, Government | 1 | 2015 | 9 | 0.120 |
Why?
|
| Reimbursement Mechanisms | 1 | 2015 | 9 | 0.120 |
Why?
|
| Hospitals, Maternity | 1 | 1995 | 3 | 0.120 |
Why?
|
| Stereotyping | 1 | 2015 | 17 | 0.120 |
Why?
|
| Schools, Medical | 1 | 2015 | 27 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 1998 | 317 | 0.120 |
Why?
|
| Birth Weight | 1 | 2014 | 46 | 0.120 |
Why?
|
| Cohort Studies | 6 | 2019 | 1890 | 0.110 |
Why?
|
| Faculty, Medical | 1 | 2015 | 44 | 0.110 |
Why?
|
| HIV Seroprevalence | 1 | 1994 | 3 | 0.110 |
Why?
|
| Syphilis | 1 | 1994 | 3 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 676 | 0.110 |
Why?
|
| Students, Medical | 1 | 2015 | 56 | 0.110 |
Why?
|
| Community Health Nursing | 1 | 1994 | 6 | 0.110 |
Why?
|
| Sexually Transmitted Diseases | 1 | 1994 | 17 | 0.110 |
Why?
|
| Postpartum Period | 1 | 1993 | 24 | 0.110 |
Why?
|
| Lymphatic Metastasis | 1 | 2012 | 93 | 0.100 |
Why?
|
| Prognosis | 2 | 2012 | 785 | 0.090 |
Why?
|
| Hemodialysis, Home | 1 | 2011 | 1 | 0.090 |
Why?
|
| Tetanus | 1 | 2011 | 1 | 0.090 |
Why?
|
| Disasters | 1 | 2011 | 2 | 0.090 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 2011 | 13 | 0.090 |
Why?
|
| Developing Countries | 1 | 2011 | 12 | 0.090 |
Why?
|
| Europe | 4 | 2010 | 58 | 0.090 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2010 | 17 | 0.090 |
Why?
|
| Models, Theoretical | 1 | 2010 | 85 | 0.090 |
Why?
|
| Hemodialysis Units, Hospital | 1 | 2009 | 1 | 0.080 |
Why?
|
| Advisory Committees | 1 | 2009 | 19 | 0.080 |
Why?
|
| Living Donors | 1 | 2009 | 16 | 0.080 |
Why?
|
| Health Services Research | 3 | 2002 | 38 | 0.080 |
Why?
|
| Prospective Studies | 4 | 2009 | 1778 | 0.080 |
Why?
|
| HIV Infections | 1 | 1994 | 466 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2009 | 77 | 0.080 |
Why?
|
| Counseling | 1 | 2008 | 42 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2009 | 270 | 0.080 |
Why?
|
| Logistic Models | 1 | 2009 | 395 | 0.070 |
Why?
|
| Interviews as Topic | 2 | 2002 | 132 | 0.070 |
Why?
|
| Mexico | 1 | 2007 | 14 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 474 | 0.070 |
Why?
|
| Early Diagnosis | 1 | 2007 | 57 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2006 | 44 | 0.060 |
Why?
|
| Patient Selection | 1 | 1987 | 194 | 0.060 |
Why?
|
| Parathyroid Hormone | 3 | 2010 | 24 | 0.060 |
Why?
|
| Unemployment | 1 | 2005 | 2 | 0.060 |
Why?
|
| Acute Disease | 1 | 2005 | 176 | 0.060 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 2004 | 3 | 0.060 |
Why?
|
| Reoperation | 1 | 2009 | 925 | 0.060 |
Why?
|
| Anemia, Sickle Cell | 1 | 2004 | 16 | 0.060 |
Why?
|
| Chest Pain | 1 | 2004 | 19 | 0.060 |
Why?
|
| Infant | 2 | 2009 | 564 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2009 | 641 | 0.060 |
Why?
|
| Glucose Tolerance Test | 2 | 2014 | 14 | 0.060 |
Why?
|
| Attitude to Health | 3 | 2011 | 99 | 0.060 |
Why?
|
| Critical Care | 1 | 2005 | 117 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 1792 | 0.060 |
Why?
|
| Educational Status | 1 | 2005 | 293 | 0.050 |
Why?
|
| Lung | 1 | 2004 | 168 | 0.050 |
Why?
|
| Disease Outbreaks | 2 | 2011 | 80 | 0.050 |
Why?
|
| Intensive Care Units | 1 | 2005 | 261 | 0.050 |
Why?
|
| Disease Progression | 1 | 2005 | 673 | 0.050 |
Why?
|
| Child | 2 | 2009 | 1295 | 0.050 |
Why?
|
| Policy | 1 | 2021 | 9 | 0.050 |
Why?
|
| Poverty Areas | 1 | 2001 | 9 | 0.050 |
Why?
|
| Aging | 1 | 2010 | 1544 | 0.050 |
Why?
|
| Health Care Surveys | 2 | 1998 | 64 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2009 | 260 | 0.050 |
Why?
|
| Medicare | 1 | 2021 | 118 | 0.040 |
Why?
|
| Phosphates | 2 | 2010 | 18 | 0.040 |
Why?
|
| Axilla | 1 | 2019 | 14 | 0.040 |
Why?
|
| Traction | 1 | 2019 | 32 | 0.040 |
Why?
|
| Life Expectancy | 1 | 2018 | 28 | 0.040 |
Why?
|
| Ontario | 1 | 2018 | 16 | 0.040 |
Why?
|
| Medical Indigency | 1 | 1998 | 2 | 0.040 |
Why?
|
| North America | 1 | 2018 | 41 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2018 | 81 | 0.040 |
Why?
|
| Italy | 1 | 2018 | 12 | 0.040 |
Why?
|
| Geography | 1 | 2018 | 16 | 0.040 |
Why?
|
| Hospital Charges | 1 | 1998 | 18 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2018 | 115 | 0.040 |
Why?
|
| Calcium | 2 | 2010 | 371 | 0.030 |
Why?
|
| Community Health Centers | 3 | 1993 | 10 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 587 | 0.030 |
Why?
|
| Pacific Islands | 1 | 1995 | 2 | 0.030 |
Why?
|
| Analgesia, Obstetrical | 1 | 1995 | 27 | 0.030 |
Why?
|
| Analgesia, Epidural | 1 | 1995 | 54 | 0.030 |
Why?
|
| Organizational Policy | 1 | 1995 | 14 | 0.030 |
Why?
|
| Fetal Macrosomia | 1 | 2014 | 1 | 0.030 |
Why?
|
| Labor, Induced | 1 | 2014 | 3 | 0.030 |
Why?
|
| Fasting | 1 | 2014 | 21 | 0.030 |
Why?
|
| Health Resources | 1 | 2014 | 23 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 43 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 1994 | 18 | 0.030 |
Why?
|
| Fetal Death | 1 | 1993 | 5 | 0.030 |
Why?
|
| Program Evaluation | 1 | 1994 | 120 | 0.030 |
Why?
|
| Medical Records | 1 | 1993 | 33 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 1994 | 164 | 0.020 |
Why?
|
| New York City | 1 | 2011 | 12 | 0.020 |
Why?
|
| Clostridium tetani | 1 | 2011 | 1 | 0.020 |
Why?
|
| Tetanus Toxoid | 1 | 2011 | 1 | 0.020 |
Why?
|
| Endemic Diseases | 1 | 2011 | 7 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2011 | 11 | 0.020 |
Why?
|
| Metronidazole | 1 | 2011 | 5 | 0.020 |
Why?
|
| Wounds, Penetrating | 1 | 2011 | 6 | 0.020 |
Why?
|
| Vaccination | 1 | 2011 | 33 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2011 | 31 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2009 | 22 | 0.020 |
Why?
|
| Asia | 1 | 2009 | 10 | 0.020 |
Why?
|
| Bicarbonates | 1 | 2009 | 2 | 0.020 |
Why?
|
| Ferritins | 1 | 2009 | 4 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 347 | 0.020 |
Why?
|
| Risk | 1 | 2009 | 204 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2009 | 25 | 0.020 |
Why?
|
| Vaginal Smears | 3 | 1993 | 11 | 0.020 |
Why?
|
| Papanicolaou Test | 3 | 1993 | 9 | 0.020 |
Why?
|
| Ethics, Institutional | 1 | 1987 | 1 | 0.020 |
Why?
|
| Insurance, Hospitalization | 1 | 1987 | 2 | 0.020 |
Why?
|
| Government Regulation | 1 | 1987 | 2 | 0.020 |
Why?
|
| Federal Government | 1 | 1987 | 3 | 0.020 |
Why?
|
| Vulnerable Populations | 1 | 1987 | 23 | 0.020 |
Why?
|
| European Continental Ancestry Group | 1 | 2006 | 3 | 0.020 |
Why?
|
| Transfer Agreement | 1 | 1986 | 1 | 0.020 |
Why?
|
| Patient Admission | 1 | 1986 | 22 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 2004 | 12 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 1368 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2005 | 130 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2004 | 27 | 0.010 |
Why?
|
| Physical Examination | 2 | 1993 | 116 | 0.010 |
Why?
|
| Health Services | 1 | 1998 | 6 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1998 | 260 | 0.010 |
Why?
|
| Computers | 1 | 1976 | 17 | 0.010 |
Why?
|
| Appointments and Schedules | 1 | 1993 | 13 | 0.010 |
Why?
|
| Data Collection | 1 | 1993 | 91 | 0.010 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1986 | 9 | 0.000 |
Why?
|
| Time | 1 | 1986 | 15 | 0.000 |
Why?
|
| Demography | 1 | 1986 | 72 | 0.000 |
Why?
|